Multiple sclerosis: should MR criteria for dissemination in time be less stringent

Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.

Lancet (London, England)·2026

Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis.

Annals of neurology·2025

Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS.

Multiple sclerosis (Houndmills, Basingstoke, England)·2025

Ethnoracial disparities in gray matter atrophy are mediated by structural disconnectivity in multiple sclerosis.

Annals of clinical and translational neurology·2025

Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.

The Lancet. Neurology·2024

Detection of diffusely abnormal white matter in multiple sclerosis on multiparametric brain MRI using semi-supervised deep learning.

Scientific reports·2024

Genetic Modifiers of ABCA1 Activity Interact with APOE Isoforms to Mediate Alzheimer's Disease Risk.

Annals of neurology·2026

Establishing Sensory Neurons as Therapeutic Targets in Peripheral Neuropathy Driven by Polyglutamine Expanded Murine ATXN3.

Annals of neurology·2026

Two Years of Ocrelizumab Treatment in Black and Hispanic People with Multiple Sclerosis in CHIMES: A Single-Arm Clinical Trial.

Annals of neurology·2026

Toward a Behavioral Reserve Model in Amyotrophic Lateral Sclerosis.

Annals of neurology·2026

Blood Biomarkers of Alzheimer's Disease and Patterns of Structural Brain Changes in the Community.

Annals of neurology·2026

Outcomes of Bilateral Globus Pallidus Internus Deep Brain Stimulation in GNAO1-Related Disorder: An International Multicenter Experience.

Annals of neurology·2026

Saturated fatty acids enhance daptomycin activity in a Fak-dependent manner in enterococci.

Microbiology (Reading, England)·2026

Growing Staphylococcus aureus in synthetic cystic fibrosis medium promotes colonization in a murine pneumonia model.

Infection and immunity·2026

Intramuscular Antibiotics Modify Infectious Outcomes in Contaminated, Ischemic Limbs.

Military medicine·2026

Risk Factors for Disease in Military Working Equines.

Military medicine·2026

From decline to resurgence: current perspectives on Mycoplasma pneumoniae.

Clinical microbiology reviews·2026

Possible Contribution of Multiple Sclerosis Pathology to Treatment-Resistant Schizophrenia: A Case Study.

Neuropsychopharmacology reports·2026

Related Experiment Videos

Multiple sclerosis: should MR criteria for dissemination in time be less stringent

Related Concept Videos

Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.

Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis.

Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS.

Ethnoracial disparities in gray matter atrophy are mediated by structural disconnectivity in multiple sclerosis.

Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.

Detection of diffusely abnormal white matter in multiple sclerosis on multiparametric brain MRI using semi-supervised deep learning.

Genetic Modifiers of ABCA1 Activity Interact with APOE Isoforms to Mediate Alzheimer's Disease Risk.

Establishing Sensory Neurons as Therapeutic Targets in Peripheral Neuropathy Driven by Polyglutamine Expanded Murine ATXN3.

Two Years of Ocrelizumab Treatment in Black and Hispanic People with Multiple Sclerosis in CHIMES: A Single-Arm Clinical Trial.

Toward a Behavioral Reserve Model in Amyotrophic Lateral Sclerosis.

Blood Biomarkers of Alzheimer's Disease and Patterns of Structural Brain Changes in the Community.

Outcomes of Bilateral Globus Pallidus Internus Deep Brain Stimulation in GNAO1-Related Disorder: An International Multicenter Experience.

Saturated fatty acids enhance daptomycin activity in a Fak-dependent manner in enterococci.

Growing Staphylococcus aureus in synthetic cystic fibrosis medium promotes colonization in a murine pneumonia model.

Intramuscular Antibiotics Modify Infectious Outcomes in Contaminated, Ischemic Limbs.

Risk Factors for Disease in Military Working Equines.

From decline to resurgence: current perspectives on Mycoplasma pneumoniae.

Possible Contribution of Multiple Sclerosis Pathology to Treatment-Resistant Schizophrenia: A Case Study.

Related Experiment Videos

Multiple sclerosis: should MR criteria for dissemination in time be less stringent

Related Concept Videos

Related Articles